Corrigendum to "Homocysteine enhances apoptosis in human bone marrow stromal cells" [Bone 39 (2006) 582-590] (DOI:10.1016/j.bone.2006.03.004);Homocysteine enhances apoptosis in human bone marrow stromal cells

Bone

Volumn 39, Issue 3, 2006, Pages 582-590

  Kim, Duk Jae ^a   Koh, Jung Min ^a   Lee, Oksun ^b   Kim, Na Jung ^b   Lee, Young Sun ^b   Kim, Yang Soon ^b   Park, Joong Yeol ^a   Lee, Ki Up ^a   Kim, Ghi Su ^a  

^a University of Ulsan College of Medicine   (South Korea)

^b Asan Institute for Life Sciences   (South Korea)

Author keywords

Apoptosis; Homocysteine; Human bone marrow stromal cells; NF B; Reactive oxygen species

Indexed keywords

CASPASE; CASPASE 3; CASPASE 8; CASPASE 9; CYTOCHROME C; DNA; GLUTATHIONE; HOMOCYSTEINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

APOPTOSIS; ARTICLE; BONE MARROW CELL; CELL TYPE; CELL VIABILITY; CONTROLLED STUDY; CYTOPLASM; CYTOSOL; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; STROMA CELL; VASCULAR ENDOTHELIUM; WESTERN BLOTTING;

EID: 33746636881     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2006.10.001     Document Type: Erratum

References (41)

1. Center J.R., Nguyen T.V., Schneider D., Sambrook P.N., and Eisman J.A. Mortality after all major types of osteoporotic fracture in men and women: an observational study. Lancet 353 (1999) 878-882
2. Browner W.S., Pressman A.R., Nevitt M.C., and Cummings S.R. Mortality following fractures in older women: the study of osteoporotic fractures. Arch Intern Med 156 (1996) 1521-1525
3. Abedin M., Tintut Y., and Demer L.L. Vascular calcification: mechanisms and clinical ramifications. Arterioscler Thromb Vasc Biol 24 (2004) 1161-1170
4. Nawroth P., Pirzer R., Fohr B., Schilling T., Ziegler R., Bierhaus A., et al. Osteoporosis and cardiovascular disease-Two sides of the same coin?. Med Klin 98 (2003) 437-446
5. Collin-Osdoby P. Regulation of vascular calcification by osteoclast regulatory factors RANKL and osteoprotegerin. Circ Res 95 (2004) 1046-1057
6. Jorgensen L., Joakimsen O., Rosvold Berntsen G.K., Heuch I., and Jacobsen B.K. Low bone mineral density is related to echogenic carotid artery plaques: a population-based study. Am J Epidemiol 160 (2004) 549-556
7. Montalcini T., Emanuele V., CEravolo R., Gorgone G., Sesti G., Perticone F., et al. Relation of low bone mineral density and carotid atherosclerosis in postmenopausal women. Am J Cardiol 94 (2004) 266-269
8. Tanko L.B., Bagger Y.Z., and Christiansen C. Low bone mineral density in the hip as a marker of advanced atherosclerosis in elderly women. Calcif Tissue Int 73 (2003) 15-20
9. Kado D.M., Browner W.S., Blackwell T., Gore R., and Cummings S.R. Rate of bone loss is associated with mortality in older women: a prospective study. J Bone Miner Res 15 (2000) 1974-1980
10. Yap S., and Naughten E. Homocystinuria due to cystathionine β-synthase deficiency in Ireland: 25 years' experience of a newborn screened and treated population with reference to clinical outcome and biochemical control. J Inherit Metab Dis 21 (1998) 738-747
11. Hak A.E., Polderman K.H., Westendorp I.C., Jakobs C., Hofman A., Witteman J.C., et al. Increased plasma homocysteine after menopause. Atherosclerosis 149 (2000) 163-168
12. Aguilar B., Rojas J.C., and Collados M.T. Metabolism of homocysteine and its relationship with cardiovascular disease. J Thromb Thrombolysis 18 (2004) 75-87
13. Welch G.N., and Loscalzo J. Homocysteine and atherothrombosis. N Engl J Med 338 (1998) 1042-1050
14. Clarke R., Daly L., Robinson K., Naughten E., Cahalane S., Fowler B., et al. Hyperhomocysteinemia: an independent risk factor for vascular disease. N Engl J Med 324 (1991) 1149-1155
15. Golbahar J., Hamidi A., Aminzadeh M.A., and Omrani G.R. Association of plasma folate, plasma total homocysteine, but not methylenetetrahydrofolate reductase C667T polymorphism, with bone mineral density in postmenopausal Iranian women: a cross-sectional study. Bone 35 (2004) 760-765
16. van Meurs J.B., Dhonukshe-Rutten R.A., Pluijm S.M., van der Klift M., de Jonge R., Lindemans J., et al. Homocysteine levels and the risk of osteoporotic fracture. N Engl J Med 350 (2004) 2033-2041
17. McLean R.R., Jacques P.F., Selhub J., Tucker K.L., Samelson E.J., Bore K.E., et al. Homocysteine as a predictive factor for hip fracture in older persons. N Engl J Med 350 (2004) 2042-2049
18. Sato Y., Honda Y., Iwamoto J., Kanoko T., and Satoh K. Homocysteine as a predictive factor for hip fracture in stroke patients. Bone 36 (2005) 721-726
19. Morries M.S., Jacques P.F., and Selhub J. Relation between homocysteine and B-vitamin status indicators and bone mineral density in older Americans. Bone 37 (2005) 234-242
20. Sato Y., Honda Y., Iwamoto J., Kanoko T., and Satho K. Effect of folate and mecobalamin on hip fractures in patients with stroke: a randomized controlled trial. JAMA 293 (2005) 1082-1088
21. Villadsen M.M., Bunger M.H., Carstens M., Stenkjaer L., and Langdahl B.L. Methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism is associated with osteoporotic vertebral fractures, but is a weak predictor of BMD. Osteoporos Int 16 (2005) 411-416
22. Miyao M., Morita H., Hosoi T., Kurihara H., Inoue S., Hoshino S., et al. Association of methylenetetrahydrofolate reductase (MTHFR) polymorphism with bone mineral density in postmenopausal Japanese women. Calcif Tissue Int 66 (2000) 190-194
23. Lubec B., Fang-Kircher S., Lubec T., Blom H.J., and Boers G.H. Evidence for McKusick's hypothesis of deficient collagen cross-linking in patients with homocystinuria. Biochim Biophys Acta 1315 (1996) 159-162
24. Raisz L.G. Homocysteine and osteoporotic fractures-Culprit or bystander?. N Engl J Med 350 (2004) 2089-2090
25. Seeman E. Pathogenesis of bone fragility in women and men. Lancet 359 (2002) 1841-1850
26. Jilka R.L., Weinstein R.S., Bellido T., Parfitt A.M., and Manolagas S.C. Osteoblast programmed cell death (apoptosis): modulation by growth factors and cytokines. J Bone Miner Res 13 (1998) 793-802
27. Sakamoto W., Isomura H., Fujie K., Deyama Y., Kato A., Nishihira J., et al. Homocysteine attenuates the expression of osteocalcin but enhances osteopontin in MC3T3-E1 preosteoblastic cells. Biochim Biophys Acta 1740 (2005) 12-16
28. Lee S.J., Kim K.M., Namkoong S., Kim C.K., Kang Y.C., Lee H., et al. Nitric oxide inhibition of homocysteine-induced human endothelial cell apoptosis by down-regulation of p53-dependent Noxa expression through the formation of S-nitrosohomocysteine. J Biol Chem 280 (2005) 5781-5788
29. Byun C.H., Koh J.M., Kim D.K., Park S.I., Lee K.U., and Kim G.S. α-Lipoic acid inhibits TNFα-induced apoptosis in human bone marrow stromal cells. J Bone Miner Res 20 (2005) 1125-1135
30. Kim G.S., Hong J.S., Kim S.W., Koh J.M., An C.S., Choi J.Y., et al. Leptin induces apoptosis via ERK/cPLA2/cytochrome c pathway in human bone marrow stromal cells. J Biol Chem 278 (2003) 21920-21929
31. Martindale J., and Holbrook N.J. Cellular response to oxidative stress: signaling for suicide and survival. J Cell Physiol 192 (2002) 1-15
32. Herrmann M., Widmann T., Colaianni G., Colucci S., Zallone A., and Herrmann W. Increased osteoclast activity in the presence of increased homocysteine concentrations. Clin Chem 51 (2005) 2348-2353
33. Hock J.M., Krishnan V., Onyia J.E., Bidwell J.P., Milas J., and Stanislaus D. Osteoblast apoptosis and bone turnover. J Bone Miner Res 16 (2001) 975-984
34. Becker J.S., Adler A., Schneeberger A., Huang H., Wang Z., Walsh E., et al. Hyperhomocysteinemia, a cardiac metabolic disease: role of nitric oxide and the p22phox subunit of NADPH oxidase. Circulation 111 (2005) 2112-2118
35. Chang L., Xu J., Yu F., Zhao J., Tang X., and Tang C. Taurine protected myocardial mitochondria injury induced by hyperhomocysteinemia in rats. Amino Acids 27 (2004) 37-48
36. Liu A.L., Zhang Z.M., Zhu B.F., Liao Z.H., and Liu Z. Metallothionein protects bone marrow stromal cells against hydrogen peroxide-induced inhibition of osteoblastic differentiation. Cell Biol. Int 28 (2004) 905-911
37. Bowie A., and O'Neill L.A. Oxidative stress and nuclear factor-kB activation. Biochem Pharmacol 59 (2000) 13-23
38. Zamora M., Merono C., Vinas O., and Mampel T. Recruitment of NF-κB into mitochondria in involved in adenine nucleotide translocase 1 (ANT1)-induced apoptosis. J Biol Chem 279 (2004) 38415-38423
39. Petronilli V., Penzo D., Scorrano L., Bernardi P., and Lisa F.D. The mitochondrial permeability transition, release of cytochrome c and cell death. J Biol Chem 276 (2001) 12030-12034
40. Bottero V., Rossi F., Samson M., Mari M., Hofman P., and Peyron J. IκBα, the NF-κB inhibitory subunit, interacts with ANT, the mitochondrial ATP/ADP translocator. J Biol Chem 276 (2001) 21317-21324
41. Aoki M., Nata T., Morishita R., Matsushita H., Nakagami H., Yamamoto K., et al. Endothelial apoptosis induced by oxidative stress through activation of NF-κB. Hypertension 38 (2001) 48-55